Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Guardant Health, Inc.GH · Entity 3238 | Chief Operating Officer | August 07, 2023 | August 08, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Guardant Health, Inc.
Report date August 07, 2023 · Filed August 08, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| STOCK OPTION (RIGHT TO BUY)SEC Table II · derivative / convertible security · Conversion / exercise price $37.50 · Expires 2033-08-07 | Direct | 104,462 |
Reported balance
After 2023-08-07 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-08-07 · Grant · Acquired 104,462 · Balance 104,462 F1: The stock option granted on August 7, 2023 vests over a four-year period. 25% of the shares subject to such award will vest on the one-year anniversary of May 2, 2023 and the remaining 75% vests monthly for the three-year period thereafter. |
| RESTRICTED STOCK UNITSSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 69,641 |
Reported balance
After 2023-08-07 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-08-07 · Grant · Acquired 69,641 · Balance 69,641 F2: This represents a restricted stock unit award granted on August 7, 2023 and vests over a four-year period. 25% of the shares subject to such award vests on the one-year anniversary of May 15, 2023, and the remaining 75% vests annually during the three-year period thereafter. F3: Not applicable for Restricted Stock Units. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock option granted on August 7, 2023 vests over a four-year period. 25% of the shares subject to such award will vest on the one-year anniversary of May 2, 2023 and the remaining 75% vests monthly for the three-year period thereafter.
F2: This represents a restricted stock unit award granted on August 7, 2023 and vests over a four-year period. 25% of the shares subject to such award vests on the one-year anniversary of May 15, 2023, and the remaining 75% vests annually during the three-year period thereafter.
F3: Not applicable for Restricted Stock Units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 07, 2023 Filed Aug 8, 2023 21:11 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRESTRICTED STOCK UNITS · Derivative | 69,641 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000127 · wk-form4_1691529078.xml · derivative · entry 2 Dahne-Steuber Ines · CIK 0001977666 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,641 Underlying: COMMON STOCK · 69,641 shares Expires not disclosed F2 · derivative.exercise_date: This represents a restricted stock unit award granted on August 7, 2023 and vests over a four-year period. 25% of the shares subject to such award vests on the one-year anniversary of May 15, 2023, and the remaining 75% vests annually during the three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| August 07, 2023 Filed Aug 8, 2023 21:11 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantSTOCK OPTION (RIGHT TO BUY) · Derivative | 104,462 | $0.00 Strike: $37.50 | $0.00 |
DisclosureSEC source: 0001576280-23-000127 · wk-form4_1691529078.xml · derivative · entry 1 Dahne-Steuber Ines · CIK 0001977666 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,462 Underlying: COMMON STOCK · 104,462 shares Expires 2033-08-07 F1 · derivative.exercise_date: The stock option granted on August 7, 2023 vests over a four-year period. 25% of the shares subject to such award will vest on the one-year anniversary of May 2, 2023 and the remaining 75% vests monthly for the three-year period thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.